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Abstract 
AIM: To evaluate the diagnostic performance of MDI and temocillin disk (30 μg) for detection of carbapenem-
resistant Enterobacteriaceae in comparison to real-time PCR. 
MATERIAL AND METHODS: Fifty specimens submitted to the Microbiology Laboratory of Ain Shams University 
Hospitals and showed resistance to carbapenem drugs through routine culture and susceptibility testing, were 
assessed by both temocillin disk (30 μg) and MDI set to detect carbapenem-resistant Enterobacteriaceae. Results 
were compared to real-time PCR for detection of carbapenemase genes blaKPC, blaNDM, blaOXA–48-like, 
blaVIM, and blaIMP.  
RESULTS: Our work revealed that most of the CPE isolates were Klebsiella species (62%) followed by E. coli 
(24%), Serratia (10%) and Citrobacter (4%). Phenotypic detection of carbapenem-resistant classes revealed OXA 
- 48 in 96% of isolates, followed by MBLs (82%), and KPC (34%).  All isolates were negative for AmpC.  Detection 
of the genes by real-time PCR showed that the predominance was for the blaOXA-48 gene (96%) then blaVIM 
(94%) followed by blaNDM (54%), blaKPC (46%) and finally blaIMP (40%). Evaluation of the MDI set against PCR 
showed sensitivity (82.1%) and specificity (70%). The temocillin disk had 97.9% sensitivity and 50% specificity.  
The evaluation of Temocillin disk and MDI in combination for detection of carbapenem-resistant 
Enterobacteriaceae showed 99.7% sensitivity and 35% specificity. 
CONCLUSION: Adding Temocillin disk to Mastdisks ID inhibitor combination set provides a simple, easy, rapid 
and highly sensitive test that can be used for screening and classification of carbapenem-resistant 
Enterobacteriaceae. However, it still needs confirmation by molecular techniques. 
 
 
 
Introduction 
 
Multidrug-resistant organisms are markedly 
increasing among bacterial species, substantially, 
Carbapenem-resistant Enterobacteriaceae which 
have been reported worldwide [1]. 
 Carbapenems are considered the drugs of 
the last choice for treating multidrug-resistant 
pathogens due to their high clinical efficacy and safety 
[2]. There is a major problem concerning resistance to 
carbapenem groups of drugs as it limits treatment 
options and thereby obligates for the use of antibiotics 
with high toxicity like tigecycline and colistin [3]. The 
most common mechanism of carbapenem resistance 
is the production of carbapenemase enzymes [2]. 
At first, carbapenemases were chromosomal - 
mediated in a few specific species, but they are now 
plasmid - mediated, or both chromosomally - and 
plasmid-mediated. This leads to the much more 
aggressive spread of resistance due to horizontal 
transmission among various bacterial species and 
genera [4]. 
Carbapenemases are classified according to 
their functional and molecular properties. Molecular 
classes A and D are the β - lactamases having serine 
at their active site, whereas molecular class B β - 
lactamases are all metalloenzymes with zinc at their 
active site [5]. 
The most clinically significant enzymes 
among the class A carbapenemases are K. 
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pneumoniae carbapenemase (KPC) enzymes. KPC-
producing K. pneumoniae are widely disseminated 
among several countries [6]. The class B beta-
lactamases or Metallo – beta-lactamases (MBLs) 
have also been identified in various enterobacterial 
species, including K. pneumonia [7]. They are mainly 
NewDelhi Metallo – beta-lactamase (NDM - 1), 
Verona integrin - encoded Metallo – beta-lactamase 
(VIM), and Imipenemase (IMP) type enzymes. NDM - 
1 is the most commonly identified worldwide. 
Carbapenem - hydrolysing oxacillinase - 48 (OXA - 
48) is the most frequently reported class D beta-
lactamase [8]. 
OXA - 48-producing isolates are frequently 
multidrug - resistant, as they combine multiple 
resistance mechanisms. This enzyme shows different 
hydrolysing activities against β - lactam antibiotics, 
with high activity against penicillins but only low 
activity against carbapenems. OXA - 48 
carbapenemase has very weak activity against third -
generation and fourth - generation cephalosporins; 
however, these are seldom a therapeutic option 
because other β - lactamases, such as extended -
spectrum β - lactamases (ESBL), are frequently 
associated [9]. The problem of OXA - 48 is that it may 
go undetected and classified as susceptible with 
imipenem and meropenem MIC of (≤ 1 μg/ml) 
according to Clinical and Laboratory Standards 
Institute (CLSI, 2015) and (≤ 2 μg/ml) according to 
European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) guidelines respectively [11]. MIC 
determination alone is not accurate for the screening 
of OXA - 48.  
Rapid detection of carbapenemases is crucial 
to ensure early detection and implementation of 
control measures in hospitals. Preliminary screening 
by Disk Diffusion should be confirmed by Modified 
Hodge test (MHT) according to the recommendation 
of CLSI [12]. However, MHT requires at least 24 - 48 
h and thereby it is time-consuming. Also, it lacks 
specificity and may give false positive results or fail to 
detect MBLs [13]. 
Molecular techniques remain the reference 
standard for the identification and differentiation of 
carbapenemases. The most common of which is 
PCR. Sequencing is sometimes done following PCR 
for precise identification of a carbapenemase, rather 
than just its group (e.g. VIM - type, KPC - type, NDM -
type, and OXA - 48 - type) [13]. 
 
 
 Materials and Methods 
 
Patient population 
This study was conducted on 50 specimens 
randomly selected from different clinical specimens 
submitted to the Microbiology Laboratory of Ain 
Shams University Hospitals for routine culture and 
susceptibility testing that showed resistance to 
carbapenem drugs by both Kirby Bauer disk diffusion 
method (They were nonsusceptible, i.e., intermediate 
or resistant to the carbapenems if zone diameter was 
< 23 for meropenem (10 μg) and imipenem (10 μg ) 
and Broth microdilution method if MICs were > 1 
μg/ml for meropenem and imipenem (10). The isolates 
included 31 (62%) Klebsiella species, 12 (24%) E.coli, 
5 (10%) Serratia and 2 (4%) Citrobacter.  
 
  
Most disks ID inhibitor combination disks 
(MDI) 
Most disks ID inhibitor combination disks 
(MDI) (Mast Diagnostics) method was performed 
according to the manufacturer’s instructions. Four 
disks were included: disk A, containing a carbapenem 
(meropenem, 10 μg); disk B, consisting of meropenem 
(10 μg) and an MBL inhibitor; disk C, consisting of 
meropenem (10 μg) with a KPC inhibitor; and disk D, 
containing meropenem (10 μg) with an AmpC 
inhibitor. The interpretation of the test is as follows. 
The zone of inhibition of disk A is compared to the 
zones of inhibition of each of disks B, C, and D. If disk 
B shows a zone difference of ≥ 5 mm from disk A, the 
organism is considered as producing MBL activity as 
in (Figure 1). If disk C shows a zone difference of ≥ 4 
mm from disk A, the organism considered as 
producing KPC activity. If disk C and disk D both show 
a zone difference of ≥ 5 mm from disk A, the organism 
is considered as producing AmpC activity coupled 
with porin loss (impermeability).  
 
 
Figure 1: Mastdisks inhibitor combination set showing MBL producing strain 
(Disk B > disk A by 5 mm) 
 
 
Detection of OXA 48 
Temocillin testing using a modified zone 
diameter cut - off of < 12 mm (Figure 2) was used as a 
tool for discriminating Ambler class D carbapenemase 
producers [14]. 
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E. coli ATCC 25922 and Klebsiella ATCC 
700603 were included as negative control.  
 
Figure 2: Disc diffusion susceptibility test showing Temocillin resistant strain 
(OXA48 producer) 
 
Genotypic Identification 
All test isolates were subcultured on blood 
agar overnight at 36
o
C, and five selected colonies 
were suspended in 1.5 ml microtubes containing 180 
µL sterile distilled water, then whole genomic DNA 
was extracted by QIAamp DNA Mini kit (QIAGEN 
Sample and Assay Technologies, Germany) 
according to manufacturer’s instruction. Suitable 
primers each targeting selected regions of the 
blaKPC, blaNDM, blaOXA – 48 - like blaVIM and 
blaIMP genes were used (Table 1). Amplification 
reactions were performed in a final volume of 25 μL 
containing 12.5 μL 2 x HRM PCR Master Mix (Thermo 
Scientific, Lithuania, EU), and two primer mix, 9.5 μL 
RNase - free H2O, and one μL of the template DNA. 
The optimized cycling protocol for High Resolution 
Melting (HRM) Analysis was as follow: initial 
denaturation at 95°C for 5 minutes followed by 40 
cycles at 95°C for 10 seconds, 55°C for 30 seconds, 
and 72°C for 10 seconds, followed by HRM analysis 
of 65 - 95°C for 2 seconds (Rotor-Gene, QIAGEN) 
[15]. 
Table 1: Primers targeting selected regions of the blaKPC, 
blaNDM, blaOXA-48-like, blaVIM, and blaIMP genes (Monteiro et 
al. 2012) 
Template Primer Sequence (5'-3') 
blaOXA-48 
 
Forward primer 
Reverse primer 
TGTTTTTGGTGGCATCGAT 
GTAAMRATGCTTGGTTCGC 
blaNDM-1 
 
Forward primer 
Reverse primer 
TTGGCCTTGCTGTCCTTG 
ACACCAGTGACAATATCACCG 
blaKPC  
 
Forward primer 
Reverse primer 
TCGCTAAACTCGAACAGG 
TTACTGCCCGTTGACGCCCAATCC 
blaIMP 
 
Forward primer 
Reverse primer 
GAGTGGCTTAATTCTCRATC 
AACTAYCCAATAYRTAAC 
blaVIM Forward primer 
Reverse primer 
GTTTGGTCGCATATCGCAAC 
AATGCGCAGCACCAGGATAG 
 
 
Results 
 
Phenotypic detection of carbapenem-resistant 
classes using carbapenemase detection set by 
(MastDiagnostics) and temocillin disk revealed that 
the highest positive results were for OXA48 (detected 
in 96% of samples), followed by MBLs (82%), then for 
KPC (34%), while all samples were negative for 
AmpC. 
Some specimens showed two or more 
positive carbapenemase producing enzymes, 46% of 
specimens were positive for both OXA 48 and MBL, 
whereas 32% specimens were positive for OXA 48, 
MBL and KPC in combination. Only 2% showed 
positive results for both OXA 48 and KPC.  
By applying real-time PCR (singleplex) to 
detect blaKPC, blaNDM, blaOXA – 48 - like, blaVIM 
and blaIMP genes in our samples, blaOXA – 48 - like 
gene showed the highest percentage (96%) followed 
by blaVIM, blaNDM, blaKPC, and blaIMP with (94%) 
(54%), (46%), and (40%), respectively (Figure 3). 
 
Figure 3: Melt data for HRM; The isolate was positive for OXA48, IMP, KPC, 
VIM and negative for NDM 
 
Statistical evaluation of the diagnostic 
performance of the carbapenemase detection set and 
temocillin disk against PCR showed, a significant 
difference between both methods regarding KPC and 
MBLs (P-value < 0.001). However, no significant 
difference was detected between temocillin disk and 
PCR regarding OXA - 48 (P value was 2.239).  
By comparing the results of temocillin disk 
specifically used for detection of OXA 48 and PCR, 47 
out of 50 specimens were true positive (97.9%) and 
one specimen was a false negative (2.1%). One out of 
two specimens was true negative (50%), and one 
specimen was false positive (50%). Temocillin disk 
had 97.9% sensitivity, 50% specificity, 97.95% PPV, 
50% NPV and efficacy was 73.95%.  
Evaluation of class A (KPC) detection by 
using disk C compared to PCR detection of the 
blaKPC gene showed that 15 out of 23 specimens 
were true positive (65.2%) and eight were a false 
negative (34.8%). Whereas 25 out of 27 were true 
negative (92.6%) and two were false positive (7.4%). 
Sensitivity, specificity, PPV, NPV was 65.2%, 92.6%, 
88.24%, 75.78% respectively and efficacy was 78.9%.  
We compared results of class B (MBL) 
detection by using disk B with PCR to detect blaVIM, 
blaNDM, and blaIMP genes. It was found that 40 out 
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of 46 (87%) specimens were true positive and six 
(13%) was a false negative. Whereas three out of 4 
(75%) specimens were true negative and one (25%) 
was a false positive. Sensitivity, specificity for PPV, 
NPV was 87%, 75%, 97.5%, 33% respectively and 
efficacy was 90.2%. 
Finally, the whole detection set was evaluated 
according to PCR. It was shown that 33 out of 40 
specimens were true positive (82.5%) and seven were 
a false negative (17.5%). Whereas seven out of ten 
specimens were true negative (70%) and three were 
false positive (30%). Overall sensitivity, specificity, 
PPV, NPV were 82.1%, 70%, 91.6%, 50% 
respectively and efficacy was 85.7%.  
Evaluation of the combined use of Temocillin 
disk and Mastdisks ID inhibitor combination set (MDI) 
in parallel for detection of carbapenem-resistant 
Enterobacteriaceae showed 99.7% sensitivity and 
35% specificity.  
 A high percentage of positive isolates for 
OXA 48 (96%) and the low percentage of negative 
OXA 48 isolates (4%) resulted in Low specificity for 
Temocillin disk as well as specificity of Temocillin disk 
and MDI in combination. One isolate was a false 
negative (2.1%), one out of two isolates (that were 
negative by PCR) was true negative (50%), and one 
was false positive (50%).  
 
 
Discussion 
 
Antibiotic resistance is a major cause for 
concern in Enterobacteriaceae family. The rate of 
resistance is increasing especially carbapenem-
resistant Enterobacteriaceae. Therefore, the need for 
a simple and accurate method is crucial for detection 
of these bacteria. 
Some phenotypic confirmation tests have 
been performed for the detection of carbapenemase-
producing Enterobacteriaceae. These include; 
modified Hodge test (MHT), inhibitor - based methods 
using metal chelators for MBLs (e.g., MBL Etest) and 
boronic acid for KPCs [13]. 
In this study, Mastdisks ID inhibitor 
combination disks kit (MDI) (Mast Diagnostics) was 
evaluated for the detection of Enterobacteriaceae 
producing carbapenemases. Sanjeev and Mehra 
(2015), stated that simultaneous using of both 
inhibitors (PBA for KPC detection and DPA for MBL 
detection) as in our study, seems to restrict the activity 
of both carbapenemases against meropenem, 
allowing the detection of isolates that co-produce 
these enzymes in almost all cases [16]. Their study 
has shown the combined use of two inhibitors can 
detect and differentiate carbapenemase production. 
However, Mastdisks combination inhibitor set was not 
designed to detect OXA – 48 - like B -lactamase in 
Enterobacteriaceae. That is why we performed disk 
diffusion assay with temocillin disk to detect OXA – 48 
- like producing Enterobacteriaceae. The high - level 
resistance to the B - lactam temocillin might be 
presumptive evidence for the presence of OXA - 48 
[17].  
We found that 96% of our isolates were 
sensitive to temocillin disk used for OXA - 48 
detection. In areas where OXA - 48 producers are 
predominant, temocillin testing using a modified zone 
diameter cut - off of < 12 mm [18], could be an easy 
and useful tool for discriminating Ambler class D 
carbapenemase producers from extended spectrum b 
- lactamases and/or AmpC - producing isolates 
among carbapenem – non - susceptible 
Enterobacteriaceae isolates. About temocillin, 98.1% 
(317/323) of the OXA – 48 - producing 
Enterobacteriaceae isolates displayed disk inhibition 
zones of < 12 mm compared with only 10.0%(92/919) 
of the carbapenemase - negative isolates [14]. 
 Also, 82% and 34% were positive for MBLs 
using disk B and KPC using disk C respectively. 
These results were concordant with a study 
conducted by Doyal and co-workers (2012) [19], who 
stated that 100%, 93% and 49% of their isolates were 
positivity for OXA - 48, MBLs and KPC detection 
respectively. Another study conducted by Andrea et 
al. (2014) [20], they found that 92% of their CPE 
isolates were OXA 48 positive, 49.5% were 
harbouring double positive KPC and MBL when used 
the Mastdisks ID inhibitor combination. Although their 
study was in Italy, their results were similar to our 
results, so we can conclude that class D is prevalent 
there like in Egypt while other classes are not.  
 A high prevalence of CPE can be found in 
southern Europe and Asia, Greece, Italy, Turkey, and 
Israel than in other parts of the world. 
Historical/cultural relationship and exchange of 
populations with other countries of high prevalence 
can influence the type of CPE. Cross-border transfer 
of patients, travel, medical tourism and refugees might 
also play an important role. This is particularly true for 
the spread of OXA - 48 in France and Belgium from 
North Africa, and in Germany, probably from Turkey, 
or the identification in UK of NDM - 1 producers of 
Indian origin. The increasing frequency of CPE could 
be related to the increasing prevalence of OXA - 48 
producers in many European countries and the 
exportation of KPC producers from Greece and Italy 
to other European countries [21].  
Some of our isolates showed double or triple 
positive for carbapenemase enzymes. Both OXA 48 
and MBL were positive in 23 isolates (46%), whereas 
32% showed positive results for OXA48, MBL and 
KPC altogether. Only (2%) were positive for OXA48 
and KPC together (2%). This means that OXA - 48 
was positive in most our isolates in combination with 
other classes. OXA - 48 enzyme in 
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Enterobacteriaceae, can give weak level carbapenem 
resistance and with cross-resistance with KPC 
enzymes and MBLs tend to confer broader effects on 
the resistance profile of the host strain [22]. OXA - 48 
enzyme was positive in most of our isolates combined 
with other resistant classes that made OXA - 48 
carbapenemase production more evident and which 
otherwise couldn’t be detected if present alone. 
In this study, we applied real-time PCR to 
detect blaKPC, blaNDM, blaOXA – 48 - like blaVIM, 
and blaIMP genes. OXA 48 gene showed the highest 
percentage (96%) then VIM (94%) followed by NDM 
(54%), KPC (46%) and finally IMP (40%). This could 
be explained by the fact that Amber class D is weak 
and needs the coexistence of other classes to be 
expressed and so had the highest percentage. Also, 
in a study conducted by Samar (2016); blaOXA – 48 -
like gene's percentage was the highest (28.6%), 
followed byblaKPC (19%), blaVIM (9.5%) and finally 
blaNDM (2.4%) [23].  
Most disks ID inhibitor combination disks had 
a sensitivity and specificity of 87% and 75% 
respectively for detecting MBL producers, 65.2% and 
92.6% respectively, for detecting KPC producers. In 
our study, evaluation of carbapenemase detection set 
for detection of all classes of CPE in comparison to 
PCR showed sensitivity 82.1%, specificity 70%, PPV 
91.6% and NPV 50%. Samar [25]; in her study stated 
that the combined disk test showed sensitivity 100% 
and specificity 88.9%. Doyal and co-workers (2012), 
stated that overall, the sensitivity and specificity for 
MDI were 78% and 93% respectively, MDI performed 
well for the detection of KPCs and NDMs but poorly 
for VIMs, IMPs, and OXA – 48 - like enzymes [19].  
 On the other hand, temocillin disk had 97.9% 
sensitivity, 50% specificity, 97.95% PPV and 50% 
NPV and efficacy was 73.95%. Another study 
conducted by Woodford et al. (2014) in England, the 
sensitivity and specificity of temocillin were 90.7% and 
88.2% respectively with PPV 27.6 % and NPV 99.5% 
[24]. 
Huang and co-workers (2014), support 
previous data and confirm that high - level resistance 
to temocillin is a highly sensitive and specific 
phenotypic surrogate marker of OXA - 48 productions 
in strains with decreased susceptibility to a 
carbapenem, although in itself it could not differentiate 
OXA - 48 from VIM - type carbapenemases [18], [25]. 
However, the overall sensitivity and specificity 
of both Temocillin disk and carbapenemase detection 
set tests in our study for detection of carbapenem-
resistant Enterobacteriaceae was 99.7% and 35% 
respectively. 
Low specificity for Temocillin disk as well as 
specificity of Temocillin disk and MDI in combination 
could be explained by the high percentage of positive 
isolates for OXA 48 (96%) and the low percentage of 
negative isolates (4%). Only two isolates were 
negative by PCR, one was true negative (50%), and 
the other was false positive (50%) thus reducing 
Temocillin disk test specificity.  
 So, adding Temocillin disk to carbapenemase 
detection set provides an easy, inexpensive, rapid and 
highly sensitive test for screening of a large number of 
isolates for CPE. However, it still needs confirmation 
by molecular techniques. 
 
 
Acknowledgement 
 
We would like to express our gratitude for 
prof. Ibrahim K. Ali for his great support and active 
guidance throughout this work.  
 
 
Financial support 
 
This research was funded by the National 
Research Centre - Egypt. 
 
 
References 
1. Singh-Moodley A, Perovic. Antimicrobial susceptibility testing in 
predicting the presence of carbapenemase genes in 
Enterobacteriaceae in South Africa. BMC Infect Dis. 2016; 16: 536. 
https://doi.org/10.1186/s12879-016-1858-7 PMid:27716102 
PMCid:PMC5050574 
2. Queenan AM, Bush K. Carbapenemases the versatile beta-
lactamases. Clin Microbiol Rev. 2007; 20(3):440–458. 
https://doi.org/10.1128/CMR.00001-07 PMid:17630334 
PMCid:PMC1932750 
 
3. Falagas M, Lourida P, Poulikakos P, et al.: Antibiotic treatment 
of infections due to carbapenem-resistant Enterobacteriaceae: a 
systematic evaluation of the available evidence. Antimicrob Agents 
Chemother. 2014; 58(2):654-663. 
https://doi.org/10.1128/AAC.01222-13 PMid:24080646 
PMCid:PMC3910850 
 
4. Fernández-Cuenca F, Rodríguez-Martínez JM, Gómez-Sánchez 
MA, et al. Production of a plasmid-encoded OXA-72 β-lactamase 
associated with resistance to carbapenems in a clinical isolate 
Acinetobacter junii. Int J Antimicrob Agents. 2012; 39(1):93–94. 
https://doi.org/10.1016/j.ijantimicag.2011.07.017 PMid:21982835  
 
5. Agila K. Pragasam, Sahni D. Rani, Anandan S, et al. A Pilot 
Study on Carbapenemase Detection: Do We See the Same Level 
of Agreement as with the CLSI Observations. Journal of Clinical 
and Diagnostic Research. 2016; 10(7): DC09-DC13. 
 
6. Walther-Rasmussen J and Hoiby N. Class A carbapenemases. J 
Antimicrob Chemother. 2007; 60:470–482. 
https://doi.org/10.1093/jac/dkm226 PMid:17595289  
 
  
7. Nordmann P, Naas T and Poirel L. Global spread of 
carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 
2011; 17:1791–1798. https://doi.org/10.3201/eid1710.110655 
PMid:22000347 PMCid:PMC3310682 
 
8. Girmenia C, Serrao A, and Canichella M. Epidemiology of 
 
Basic Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
6 https://www.id-press.eu/mjms/index 
 
Carbapenem Resistant Klebsiella pneumoniae Infections in 
Mediterranean Countries. Mediterr J Hematol Infect Dis. 2016; 
8(1): e2016032. https://doi.org/10.4084/mjhid.2016.032 
PMid:27441063 PMCid:PMC4943068 
9. Poirel L, Potron A, and Nordmann P. OXA-48-like 
carbapenemases: the phantom menace. J Antimicrob Chemother, 
2012; 67: 1597–1606. https://doi.org/10.1093/jac/dks121 
PMid:22499996  
 
10. Clinical Laboratory Standards Institute. Performance standards 
for antimicrobial susceptibility testing, 25 thin formational 
supplements. CLSI, document M100-S25, Wayne PA, 2015. 
 
11. Nordmann P, Gniadkowski M, Giske CG, et al. Identification 
and screening of carbapenemase-producing Enterobacteriaceae. 
Clinical Microbiology and Infection. 2012; 18 (5): 432–438. 
https://doi.org/10.1111/j.1469-0691.2012.03815.x PMid:22507110  
 
12. Patel J, Cockerill F, Bradford P, et al. Clinical and Laboratory 
Standards Institute, Performance Standards for Antimicrobial 
Susceptibility Testing; Twenty first Informational Supplement. CLSI 
document M100-21. Wayne, PA: Clinical and Laboratory Standards 
Institute, 2011: 35(3). 
 
13. Nordmann P, Poirel L. Strategies for identification of 
carbapenemase-producing Enterobacteriaceae. J Antimicrob 
Chemother. 2013; 68:487–489. https://doi.org/10.1093/jac/dks426 
PMid:23104494  
 
14. Huang T, Poirel L, Pierre, Bogaerts P et al. Temocillin and 
piperacillin/tazobactam resistance by disk diffusionas antimicrobial 
surrogate markers for the detection of carbapenemase-producing 
Enterobacteriaceae in geographical areas with a high prevalence 
of OXA-48 producers. J Antimicrob Chemother. 2014; 69: 445–
450. https://doi.org/10.1093/jac/dkt367 PMid:24055766  
 
15. Monteiro J, Widen H R, Pignatari C A, et al. Rapid detection of 
carbapenemase genes by multiplex real-time PCR. Journal of 
Antimicrobial Chemotherapy. 2012; 67(4), 906-909. 
https://doi.org/10.1093/jac/dkr563 PMid:22232516  
 
16. Sanjeev K, Mehra SK. Performance of Modified Hodge Test 
and Combined Disk Test for Detection of Carbapenemases in 
Clinical Isolates of Enterobacteriaceae. Int J Curr Microbiol App 
Sci. 2015: 772-783. 
 
17. Glupczynski Y, Huang TD, Bouchahrouf W, et al. Rapid 
emergence and spread of OXA-48-producing carbapenem-
resistant Enterobacteriaceae isolates in Belgian hospitals. Int J 
Antimicrob Agents. 2012; 39:168 –172. 
 
https://doi.org/10.1016/j.ijantimicag.2011.10.005 PMid:22115539  
18. Hartl R, Widhalm S, Kerschner H, et al. Temocillin and 
meropenem to diskriminate resistance mechanisms leading to 
decreased carbapenem susceptibility with focus on OXA-48 in 
Enterobacteriaceae. Clin Microbiol Infect. 2013; 19: E230–232. 
https://doi.org/10.1111/1469-0691.12146 PMid:23397897  
 
19. Doyal D, Peirano G, Lascols C, et al. Laboratory detection of 
Enterobacteriaceae that produce carbpenemases. J, Clin. 
Microbiol. 2012; 50(12):3877-3880. 
https://doi.org/10.1128/JCM.02117-12 PMid:22993175 
PMCid:PMC3503014 
 
20. Andrea B, Ilaria F, Antonietta C, et al. Comparison of 
phenotypic methods for the detection of carbapenem non-
susceptible Enterobacteriaceae. J BMC Infectious Diseases. 2014; 
6:3-7. 
 
21. Canton R, Akova M, Carmeli Y, et al. Rapid evolution and 
spread of carbapenemases among Enterobacteriaceae in Europe. 
Clinical Microbiology and Infection. 2012; 18(5) 414-431. 
https://doi.org/10.1111/j.1469-0691.2012.03821.x PMid:22507109  
 
22. UK Standards for Microbiology Investigations (UK SMI). 
Detection of bacteria with carbapenem-hydrolysing β-lactamases 
(carbapenemases), PHE Bacteriology, 2015: 60. 
 
23. Samar S. Comparative evaluation of phenotypic and genotypic 
methods for detection of carbapenemases in clinically significant 
Klebsiella pneumonia isolates. Egyptian Journal of Medical 
Microbiology. 2016; 25(1):109-116. 
https://doi.org/10.12816/0037099 
 
24. Woodford N, Pike R, Meunier D, et al. In vitro activity of 
temocillin against multidrug-resistant clinical isolates of Escherichia 
coli, Klebsiella spp. And Enterobacter spp., and evaluation of high-
level temocillin resistance as a diagnostic marker for OXA-48 
carbapenemase. J Antimicrob. Chemother. 2014; 69:564-567. 
https://doi.org/10.1093/jac/dkt383 PMid:24080500  
 
25. Livermore DM, Warner M, Mushtaq S et al. What remains 
against carbapenem-resistant Enterobacteriaceae? Evaluation of 
chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, 
nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents. 
2011; 37: 415–419. 
https://doi.org/10.1016/j.ijantimicag.2011.01.012 PMid:21429716  
 
 
